© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Hoth Therapeutics, Inc. (HOTH) shows an Average True Range (ATR) of 0.07 and an Enterprise Value of -4.08M. Its average trading volume over the past 3 months is 560.66K, indicating liquidity. These fundamental metrics provide insight into HOTH's underlying financial health and market activity.
Hoth Therapeutics, Inc. (HOTH) technical indicators as of December 22, 2025: the SMA 20 is -5.16%, SMA 50 at -13.66%, and SMA 200 at -10.5%. The RSI 14 value is 39.72, suggesting its current momentum. These technical analysis signals help assess HOTH's price trends and potential future movements.
Hoth Therapeutics, Inc. (HOTH) stock performance overview as of December 22, 2025: The 52-week high is $3.8 (currently -71.32% below), and the 52-week low is $0.655 (currently 66.31% above). Over the past year, HOTH's performance is 34.57%, compared to the S&P 500's 12.87% change.
According to market data, Hoth Therapeutics, Inc. (HOTH) stock's recent performance metrics show that over the last month, HOTH is -7.63%, with a Year-to-Date (YTD) performance of 45.7%. Over the past year, the stock has seen a 34.57% change. These figures summarize HOTH's price movements across various periods, reflecting its historical returns.
According to current financial data, HOTH stock's P/E (TTM) ratio is -1.41, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for HOTH, including P/S (N/A), P/B (1.47), and P/FCF (-1.64), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.